Combination of radiotherapy and chemotherapy is advisable in all patients with clinical stage I-II Hodgkin's disease, six-year results of the EORTC-GPMC controlled clinical trials 'H7-VF', 'H7-F' and 'H7-U'.
被引:28
作者:
Noordijk, EM
论文数: 0引用数: 0
h-index: 0
Noordijk, EM
Carde, P
论文数: 0引用数: 0
h-index: 0
Carde, P
Hagenbeek, A
论文数: 0引用数: 0
h-index: 0
Hagenbeek, A
Mandard, AM
论文数: 0引用数: 0
h-index: 0
Mandard, AM
KluinNelemans, J
论文数: 0引用数: 0
h-index: 0
KluinNelemans, J
Thomas, J
论文数: 0引用数: 0
h-index: 0
Thomas, J
Tirelli, U
论文数: 0引用数: 0
h-index: 0
Tirelli, U
Monconduit, M
论文数: 0引用数: 0
h-index: 0
Monconduit, M
Eghbali, H
论文数: 0引用数: 0
h-index: 0
Eghbali, H
Burgers, JMV
论文数: 0引用数: 0
h-index: 0
Burgers, JMV
Dupouy, N
论文数: 0引用数: 0
h-index: 0
Dupouy, N
HenryAmar, M
论文数: 0引用数: 0
h-index: 0
HenryAmar, M
机构:
来源:
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
1997年
/
39卷
/
02期